申请人:Otsubo Kenji
公开号:US20100130546A1
公开(公告)日:2010-05-27
The present invention provides a quinolone compound represented by General Formula (1)
or a salt thereof, wherein R
1
represents a hydrogen atom, etc.; R
2
represents a hydrogen atom, etc.; R
3
represents a phenyl group optionally being substituted with one or more substituents, etc.; R
4
represents a halogen atom; R
5
represents a hydrogen atom or halogen atom; R
6
represents a hydrogen atom; and R
7
represents a hydroxyl group, etc. The quinolone compound have a functional improvement effect, which suppresses progression of neurological dysfunction by inhibiting the chronic progression of Parkinson's disease or protecting dopamine neurons from the disease etiology, thereby prolonging the period before first administration begins.
本发明提供了一种喹诺酮化合物,其由通式(1)或其盐所表示,其中R1表示氢原子等;R2表示氢原子等;R3表示苯基,该苯基可以选择性地被一个或多个取代基取代等;R4表示卤素原子;R5表示氢原子或卤素原子;R6表示氢原子;R7表示羟基等。该喹诺酮化合物具有功能改善效果,通过抑制帕金森病的慢性进展或保护多巴胺神经元免受疾病病因的影响,从而延长首次给药前的期间,抑制神经功能障碍的进展。